156 related articles for article (PubMed ID: 28452053)
1. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
2. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
[TBL] [Abstract][Full Text] [Related]
3. The survival impact of significant delays between surgery and radiochemotherapy in glioblastoma patients: A retrospective analysis from a large tertiary center.
Magrowski Ł; Nowicka E; Masri O; Tukiendorf A; Tarnawski R; Miszczyk M
J Clin Neurosci; 2021 Aug; 90():39-47. PubMed ID: 34275579
[TBL] [Abstract][Full Text] [Related]
4. Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients.
Zur I; Tzuk-Shina T; Guriel M; Eran A; Kaidar-Person O
Sci Rep; 2020 Jun; 10(1):9595. PubMed ID: 32533126
[TBL] [Abstract][Full Text] [Related]
5. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
7. Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer.
Verma V; Surkar SM; Moreno AC; Lin C; Simone CB
Cancer Med; 2018 May; 7(5):1604-1611. PubMed ID: 29603669
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma in the elderly: treatment patterns and survival.
Pretanvil JA; Salinas IQ; Piccioni DE
CNS Oncol; 2017 Jan; 6(1):19-28. PubMed ID: 28001088
[TBL] [Abstract][Full Text] [Related]
9. Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
Li G; Zhai Y; Wang Z; Wang Z; Huang R; Jiang H; Li R; Feng Y; Chang Y; Jiang T; Zhang W
Cancer Med; 2020 Mar; 9(6):1955-1965. PubMed ID: 31851783
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection.
Ahn S; Park JS; Song JH; Jeun SS; Hong YK
World Neurosurg; 2020 Jan; 133():e640-e645. PubMed ID: 31568907
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features and Prognostic Factors of Pediatric Glioblastoma: Report of 38 Cases.
Jiao Y; Wang M; Liu X; Wang J; Wang Z; Luo W; Yu Y; Sun H
World Neurosurg; 2021 Sep; 153():e105-e111. PubMed ID: 34129988
[TBL] [Abstract][Full Text] [Related]
12. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
Cassidy RJ; Switchenko JM; Cheng E; Jiang R; Jhaveri J; Patel KR; Tanenbaum DG; Russell MC; Steuer CE; Gillespie TW; McDonald MW; Landry JC
Cancer; 2017 Nov; 123(22):4325-4336. PubMed ID: 28759121
[TBL] [Abstract][Full Text] [Related]
13. Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis.
Kalra B; Kannan S; Gupta T
J Neurooncol; 2020 Jan; 146(2):311-320. PubMed ID: 31894517
[TBL] [Abstract][Full Text] [Related]
14. A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.
Straube C; Kessel KA; Antoni S; Gempt J; Meyer B; Schlegel J; Schmidt-Graf F; Combs SE
Radiat Oncol; 2020 May; 15(1):97. PubMed ID: 32375830
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting survival in glioblastoma patients below and above 65 years of age: A retrospective observational study.
Yavuz BB; Kanyilmaz G; Aktan M
Indian J Cancer; 2021; 58(2):210-216. PubMed ID: 33402568
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.
Chandra A; Lopez-Rivera V; Ryba B; Chandran AS; Brandel MG; Dono A; Sheinberg DL; Esquenazi YL; Aghi MK
Clin Neurol Neurosurg; 2024 Jan; 236():108084. PubMed ID: 38141552
[TBL] [Abstract][Full Text] [Related]
17. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
Zhang M; Li R; Pollom EL; Amini A; Dandapani S; Li G
J Clin Neurosci; 2020 Dec; 82(Pt A):122-127. PubMed ID: 33317719
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Surgery and Adjuvant Therapy on Survival Outcomes in Clear Cell Ependymomas: A Systematic Review and Meta-Analysis of Individual Patient Data.
Sheen Kweh BT; Rosenfeld J; Hunn M; Tee JW
World Neurosurg; 2021 Jan; 145():229-240. PubMed ID: 32949795
[TBL] [Abstract][Full Text] [Related]
20. Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery?
Lopez-Rivera V; Dono A; Lewis CT; Chandra A; Abdelkhaleq R; Sheth SA; Ballester LY; Esquenazi Y
Clin Neurol Neurosurg; 2021 Mar; 202():106474. PubMed ID: 33454497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
